Starling William N JR 4

4 · TRANSENTERIX INC. · Filed Apr 26, 2019

Form 4

Period: 2019-04-25

Director

Transactions

Award
Stock Option Award
2019-04-25+29,104→ 29,104 total
Exercise: $1.96Exp: 2029-04-25→ Common Stock (29,104 underlying)
Award
Common Stock
2019-04-25+20,380→ 20,380 total

Holdings

Footnotes (6)

[F1]Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
[F2]The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period.
[F3]Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.
[F4]Shares of Common Stock held by Synecor, L.L.C. Willam N. Starling is the chief executive officer of Synecor, L.L.C.
[F5]Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
[F6]The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. Subject to acceleration of vesting in full upon consummation of a change in control of the registrant.

Documents

1 file